These pre-malignant senescent cells are usually eliminated by the CD4-positive (CD4+) T cell-mediated adaptive immune response, but impairment of this system by CD4+ T cell deficiency results in the development of hepatocellular carcinoma. The gene discussed is CD4; the disease is congenital T-cell immunodeficiency.